Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhibition of Ovulation with Estradiol/Drospirenone Regimens
NCT00631124Phase 2Completed
- Sponsor
- Bayer
- Start
- Feb 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of estradiol + drospirenone in contraception, sponsored by Bayer. Started Feb 2008; status: completed.
02
Drugs
estradiol + drospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00631124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00631124.